Cargando…

A review of the pharmacology and clinical efficacy of brivaracetam

Brivaracetam (BRV; Briviact) is a new antiepileptic drug (AED) approved for adjunctive treatment of focal (partial-onset) seizures in adults. BRV is a selective, high-affinity ligand for synaptic vesicle 2A (SV2A) with 15- to 30-fold higher affinity than levetiracetam, the first AED acting on SV2A....

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Pavel, Diaz, Anyzeila, Gasalla, Teresa, Whitesides, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783144/ https://www.ncbi.nlm.nih.gov/pubmed/29403319 http://dx.doi.org/10.2147/CPAA.S114072

Ejemplares similares

Time course of 75%–100% efficacy response of adjunctive brivaracetam
por: Klein, Pavel, et al.
Publicado: (2020)

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
por: Ben-Menachem, Elinor, et al.
Publicado: (2016)

Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review
por: Lee, Kiwon, et al.
Publicado: (2022)

Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa, Anteneh M
Publicado: (2019)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
por: Mumoli, Laura, et al.
Publicado: (2015)

Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience
por: Steinhoff, Bernhard J., et al.
Publicado: (2019)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis
por: Song, Ting, et al.
Publicado: (2023)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures [Corrigendum]
Publicado: (2015)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
por: Stephen, Linda J., et al.
Publicado: (2017)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Clinical and Electroencephalography Assessment of the Effects of Brivaracetam in the Treatment of Drug-Resistant Focal Epilepsy
por: Savastano, Ersilia, et al.
Publicado: (2021)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
por: Gao, Lan, et al.
Publicado: (2016)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Willems, Laurent M., et al.
Publicado: (2018)

Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug
por: Gayke, Manoj, et al.
Publicado: (2022)

Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
por: Abraira, L., et al.
Publicado: (2021)

Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice
por: Stefanatou, Maria, et al.
Publicado: (2021)

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design
por: Bast, Thomas, et al.
Publicado: (2022)

In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells
por: Rizzo, Ambra, et al.
Publicado: (2017)

Rise of the Machines? Predicting Brivaracetam Response Using Machine Learning
por: Terman, Samuel W.
Publicado: (2021)

Synthesis of the Brivaracetam Employing Asymmetric Photocatalysis and Continuous Flow Conditions
por: Franco, Marcelo S., et al.
Publicado: (2023)

Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study
por: Maschio, Marta, et al.
Publicado: (2020)

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
por: Löscher, Wolfgang, et al.
Publicado: (2021)

A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam
por: Ciceri, Samuele, et al.
Publicado: (2018)

Brivaracetam attenuates pain behaviors in a murine model of neuropathic pain
por: Tsymbalyuk, Solomiya, et al.
Publicado: (2019)

First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
por: Menzler, Katja, et al.
Publicado: (2019)

Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model
por: Nygaard, Haakon B, et al.
Publicado: (2015)

An uncommon case of nonconvulsive status epilepticus successfully treated with enteral brivaracetam
por: De Liso, Alfredo, et al.
Publicado: (2021)

Brivaracetam Induced Encephalopathy: Why Mend Something Which isn't Broken
por: Agarwal, Ayush, et al.
Publicado: (2022)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals
por: Beaty, Silky, et al.
Publicado: (2021)

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
por: Villanueva, Vicente, et al.
Publicado: (2023)

Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
por: Schoemaker, Rik, et al.
Publicado: (2017)

Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland
por: Väätäinen, Saku, et al.
Publicado: (2019)

Extrapolation of a Brivaracetam Exposure–Response Model from Adults to Children with Focal Seizures
por: Schoemaker, Rik, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3u2vs9vh52rm0pj81ek8bqptt6